UBS Group
GPATW

UBS Group’s GP-Act III Acquisition Corp Warrants GPATW Stock Holding History

UBS Group’s Portfolio GPATW Stock Details GPATW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-900
Closed -$243 – 11359
2025
Q4 		$243 Buy
900
+627
+230% +$201 ﹤0.01% 10086
2025
Q3 		$71 Sell
273
-60
-18% -$16 ﹤0.01% 9977
2025
Q2 		$100 Sell
333
-1,868
-85% -$496 ﹤0.01% 10005
2025
Q1 		$409 Buy
2,201
+2,199
+109,950% +$361 ﹤0.01% 9789
2024
Q4 		$0 Buy
+2
New – ﹤0.01% 10545

Other funds holding GPATW

HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LPC
Lineage Point Capital Palm Beach, Florida $409M AUM
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

UBS Group's GPATW Position: Q1 2026 in Review

UBS Group sold out of GP-Act III Acquisition Corp Warrants (GPATW) in Q1 2026, closing a stake of 900 shares — an estimated $243 sold.

UBS Group first reported a position in GPATW in Q4 2024 and held it in 5 quarters. The position peaked at $409 in Q1 2025. 32 funds tracked by Wall St. Rank hold GPATW as of Q1 2026.

  • UBS Group reported no remaining GP-Act III Acquisition Corp Warrants position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 900 GP-Act III Acquisition Corp Warrants shares in Q1 2026, an estimated $243.
  • UBS Group first reported a position in GP-Act III Acquisition Corp Warrants in Q4 2024 and held it in 5 quarters.
  • UBS Group's GP-Act III Acquisition Corp Warrants position peaked at $409 in Q1 2025.
  • 32 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp Warrants as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.